From a twinkle in the eye to a blockbuster drug

Authors
Citation
P. Needleman, From a twinkle in the eye to a blockbuster drug, RES TECH M, 44(6), 2001, pp. 38
Categorie Soggetti
Management,"Engineering Management /General
Journal title
RESEARCH-TECHNOLOGY MANAGEMENT
ISSN journal
08956308 → ACNP
Volume
44
Issue
6
Year of publication
2001
Database
ISI
SICI code
0895-6308(200111/12)44:6<38:FATITE>2.0.ZU;2-J
Abstract
Drug discovery and development remains an arduous and risky enterprise, des pite the unprecendented Power of genomics and other tools. The story behind Celebrex (R) (celecoxib), a highly successful medicine for arthritis, illu strates the importance of key management practices in the R&D process. A su ccessful head of R&D must (1) select excellent targets for drug discovery, (2) drive rapidly to "killer" experiments that provide decision-critical in formation, (3) focus limited resources to enhance speed, (4) break down bar riers between research and manufacturing, and (5) manage product life cycle s effectively.